TB-500 vs TB4 Fragment: Key Differences Explained (2026)
TB-500 vs TB4 Fragment (17-23): what's actually different, which one researchers use for specific applications, dosage comparisons, and why the naming is so confusing.
TB-500 vs TB4 Fragment: What's Actually the Difference?
Short answer: TB-500 is the TB4 fragment — specifically, the synthetic 7-amino-acid sequence (amino acids 17-23) of the full 43-amino-acid Thymosin Beta-4 protein. "TB4 Frag," "TB4-Frag 500," and "TB-500" all refer to the same fragment; "TB4" alone can mean either the full protein or get used loosely as shorthand for the fragment, which is where most of the confusion starts.
If you've been researching healing peptides, you've almost certainly hit a wall of confusing terminology: TB-500, TB4, TB4-Frag, thymosin beta-4, fragment 17-23. These terms are often used interchangeably — but they're not the same thing.
Here's the clearest breakdown you'll find.
---
Quick Answer
| Term | What It Actually Is |
|------|-------------------|
| Thymosin Beta-4 (TB4) | Full 43-amino acid protein found naturally in the body |
| TB-500 | Synthetic peptide of the active fragment of TB4 (amino acids 17-23) |
| TB4 Fragment / TB4-Frag 500 | Same as TB-500 — just a different naming convention |
| Fragment 17-23 | The specific amino acid sequence: Ac-LKKTETQ |
The bottom line: TB-500 is the fragment. When people search "TB4 frag vs TB500" or "tb4 fragment 17-23," they're essentially asking about the same peptide referred to in two different ways.
---
Why Is It So Confusing?
The confusion comes from how these peptides are marketed and discussed in research communities.
When someone asks "is TB-500 the same as thymosin beta-4?" — the answer is no, not exactly. TB-500 is the active fragment of TB4, not the full protein. But it contains the region responsible for most of TB4's biological activity.
---
Full TB4 vs TB-500 Fragment: Detailed Comparison
Structure
Bioavailability
TB-500's smaller size gives it a key advantage: it's more bioavailable and travels more easily through tissues than the full TB4 protein. This is why most research uses TB-500 rather than the full protein — you get the same (or better) activity at lower doses.
Mechanism of Action
Both TB4 and TB-500 work through the same pathway: actin upregulation. Actin is the protein that drives cell migration, which is essential for wound healing, tissue repair, and angiogenesis (new blood vessel formation). Our mechanism of action guide covers this pathway in more depth.
The fragment 17-23 sequence is specifically responsible for TB4's actin-binding activity. The rest of the TB4 protein has other functions, but for healing and repair research, the fragment captures the most studied effects — see our fragment 17-23 guide for a closer look at the sequence itself.
Research Applications
| Application | Full TB4 | TB-500 Fragment |
|-------------|----------|----------------|
| Wound healing | ✓ | ✓ (more studied) |
| Muscle recovery | ✓ | ✓ |
| Tendon/ligament repair | ✓ | ✓ |
| Cardiac protection | ✓ | Limited data |
| Hair growth | ✓ | Some evidence |
| Systemic availability | Lower | Higher |
---
TB4 Frag 500: The Third Name
"TB4 Frag 500" or "TB4-Frag 500" is simply another commercial name for TB-500. The "500" refers to the ~500 Da molecular weight range of the peptide fragment, not a dosage amount.
If you see these listed as separate products in research catalogs, verify the sequence. They should both be Ac-LKKTETQ. If so, they are functionally identical.
---
Which Do Researchers Use?
In the published literature, thymosin beta-4 (full protein) is the focus of most formal studies. However, because TB4 is harder to synthesize in pure form and is more expensive, the research community has largely shifted to studying the TB-500 fragment as a practical proxy.
Most community-reported research protocols use TB-500 at doses of 2–5mg per week, administered subcutaneously or intramuscularly, in 4–12 week cycles. See our dosage protocol guide and half-life and timing guide for how those numbers are typically derived.
---
TB-500 vs BPC-157: A Different Comparison Entirely
These two are often confused but work through completely different mechanisms:
Many researchers combine both for what they report as synergistic repair effects. For a full breakdown, see our TB-500 vs BPC-157 comparison guide.
---
Frequently Asked Questions
Is TB4 Frag the same thing as TB-500?
Yes, functionally. "TB4 Frag," "TB4-Frag 500," and "TB-500" are different commercial names for the same synthetic 7-amino-acid sequence (Ac-LKKTETQ). If a supplier lists them as separate products, check that the sequence matches — if it does, they are the same compound.
Is TB-500 stronger than full TB4?
"Stronger" isn't quite the right frame. TB-500 is smaller and more bioavailable, so it may reach tissue more efficiently at a given dose, but the full TB4 protein carries additional biological activity outside the actin-binding region that the fragment doesn't include. Most research and commercial availability has shifted toward the fragment because it's cheaper to synthesize and easier to study, not because it's been shown to outperform the full protein.
Can you use TB4 and TB-500 in the same protocol?
Because they're understood to work through the same actin-binding mechanism, combining full TB4 and the TB-500 fragment isn't typically described as additive in the way stacking TB-500 with a different-mechanism peptide like BPC-157 might be. Most research protocols use one or the other rather than both.
What does the "500" in TB-500 actually mean?
It refers to the fragment's approximate molecular weight range (roughly 500 Da), not a dosage amount or product strength. This is a common point of confusion — "500" in the name has nothing to do with milligrams.
Why do most suppliers sell TB-500 instead of full TB4?
Full-length TB4 is harder and more expensive to synthesize at high purity. The fragment captures the actin-binding activity most relevant to wound healing and tissue-repair research at a fraction of the production cost, which is why the research and commercial supply has concentrated around TB-500. Our peptide buying guide covers what to look for when sourcing it.
---
Summary
---
This article is for informational and research purposes only. TB-500 is not approved by the FDA for human use. Always consult relevant regulations before purchasing research peptides.